(MENAFN- Swissinfo) The Swiss government has signed a deal with US biotech firm Moderna to secure early access to 4.5 million doses of a Covid-19 vaccine currently in development.
This content was published on August 7, 2020 - 09:23 August 7, 2020 - 09:23
swissinfo.ch/dos Swiss authorities said on Friday that Moderna was 'already at an advanced stage with its vaccine project', but they did not mention a possible time frame for delivery.
They also said the 4.5 million batches would make it possible to vaccinate 2.25 million people, since double doses are expected to be necessary.
Moderna's Covid-19 vaccine, with ingredients manufactured by Swiss pharma firm Lonza, is based on an innovative mRNA technology, the government writes:
'mRNA is a kind of messenger molecule that carries the building instructions for the production of proteins. This tells the body's cells how to produce the virus protein. As soon as the protein is produced in the body, it is identified as an antigen by the immune system, which then produces antibodies against the virus, thus preparing the body to combat the real virus.'
MENAFN0708202002100000ID1100599403
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.